On January 28, Russian vaccine developer Sputnik V, Center for Research on Epidemiology and Microbiology Gamaleya of the Russian Ministry of Health expressed his willingness to help Europe in adding enough vaccine source to implement the Block’s vaccination program. Of course, this will need the Union to approve their vaccine.
|Vaccine AstraZeneca is causing controversy in Europe because of preference for UK orders. Photo: AP|
“The EU should focus on having a diversified vaccine portfolio. Sputnik V is ready to help with that,” said the Gamaleya Institute.
According to Gamaleya, the European Pharmaceutical Authority needs to speed up appraisal with vaccines produced in many other parts of the world, such as Russia and China, instead of relying only on vaccines produced in the bloc and from copper. vaccines such as vaccine Pfizer-BioNTech, vaccine AstraZeneca. This helps the EU “solve the immediate problem of supply and reduce dependence” on its limited factories.
Not only the Gamaleya Institute, but also Russian officials have repeatedly expressed their enthusiasm to support the EU vaccine supply, calling for a stop of politicization of the issue because it is a humanitarian issue and a matter of life.
The Russian Sputnik V vaccine is still “on the table” and may be considered for approval by the EU in early February.
For now, Brussels has prioritized deals with three pharmaceutical companies – US-based giants Pfizer and Moderna and UK-based AstraZeneca – in an effort to secure the bloc’s joint vaccination programs.
Unfortunately, bad news continues to happen.
The European Commission of Vaccine Experts Stella Kyriakides on Jan. 28 criticized AstraZeneca for the delay in the shipments to the alliance. The company agreed to “do its best” to deliver the agreed bulk volumes, but in the end they still responded to the previous orders of other buyers, namely the UK.
“We reject the logic of first come first served. It can work for the butcher in the neighborhood, not in the contract” – Ms. Kyriakides said.
She called on AstraZeneca “to comply with contractual obligations and to social ethics”.
The UK has requested to receive all the doses of the vaccine paid for, after the EU asked AstraZeneca to navigate supplies out of the UK, Reuters said.
The UK manufacturer’s vaccine is also not overestimated. German Committee of Vaccine Experts COVID-19 recently said that the AstraZeneca vaccine should only be given to people between the ages of 18-64.
“There are not enough data to evaluate the effectiveness of the vaccine in people 65 years and older” – Standing Committee on Vaccines announced on 28/1.
“AstraZeneca vaccine is not an mRNA vaccine, it should only be given to people between the ages of 16-64,” the statement states.
This startling statement further chaos the epidemic situation in the EU.
In a statement released yesterday, two pharmaceutical companies Pfizer (USA) and BioNTech (Germany) said the vaccine of this joint venture is effective against virus variants from England and South Africa. Accordingly, although there are “slight differences” in the trials of the new variant from the original variant, the recent variants “are unlikely to lead to a significant decline in vaccine efficacy”. .
However, the US pharmaceutical company has not been able to provide an adequate amount of vaccine under the European vaccination program.
According to the director of the World Health Organization (WHO) in Europe, Mr. Hans Kluge, a total of 35 European countries have implemented the COVID-19 vaccination program with 25 million doses already injected.
According to Kluge, the infection rate across Europe is “still very high, affecting the health system and depleting resources, making the easing too early”.
According to the Worldometers website, an additional 569,000 new infections have been reported globally and more than 15,800 people have died from the Covid-19 pandemic in the past 24 hours.
As of 6 am on January 29, the new strain corona virus continued to attack 219 countries and territories, infecting nearly 102 million people and killing nearly 2.2 million others.
Continuing to top the list of victims of the pandemic, the United States experienced the day of death when adding 3,350 deaths to the list of 443,000 deaths. The country also added 139,500 new infections, bringing the number of Covid-19-positive cases to over 26.3 million.
Brazil and the UK both had Covid-19 deaths in the past 24 hours at over 1,000 and tens of thousands of new cases.